Higher-dose ocrelizumab depletes more B cells but does not slow MS progression
A major analysis shows that more drug exposure does not always mean better disease control, as high-dose ocrelizumab cleared more…
Breaking health news, medical updates, policy changes, and public health developments from around the world. We deliver timely, accurate health journalism to keep you informed and aware.
A major analysis shows that more drug exposure does not always mean better disease control, as high-dose ocrelizumab cleared more…
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have…
New Alzheimer’s drugs are raising hopes, but modest benefits, ARIA safety risks, high costs, and regulatory disagreements show how uncertain…
A first-in-class PET imaging approach can accurately detect a biomarker for chronic traumatic encephalopathy (CTE), a devastating neurodegenerative disease associated…
A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose…
High-risk localized and locally advanced prostate cancer patients treated with apalutamide – a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)…
At the ASCO annual meeting, Dana-Farber’s Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing…
Scientists from Tokyo Metropolitan University have revealed key parts of the biochemical pathways connecting stress to sexual dysfunction. By studying…
A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that implanting…
Worldwide, at least 40 million children aged 13–15 use tobacco products, and young people’s use of e-cigarettes and nicotine pouches…